Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2025-12-26 @ 2:00 AM
NCT ID:
NCT00410605
Group ID:
EG000
Title:
Bevacizumab, Dexamethasone, and Lenalidomide
Description:
Patients receive bevacizumab IV over 30-90 minutes on days 1 and 15, oral lenalidomide on days 1-21, and oral dexamethasone on days 1, 8, 15, and 22. Courses repeat every 4 weeks in the absence of disease progression or unacceptable toxicity.
bevacizumab: Given IV
lenalidomide: Given orally
dexamethasone: Given orally
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
22
Serious Number At Risk:
39
Other Number Affected:
39
Other Number At Risk:
39
Study:
NCT00410605
Results Section:
NCT00410605
Adverse Events Module:
NCT00410605